DNDN and NUVO thoughts

Unfortunately the market couldn't plow forward due to ongoing economical concerns. DNDN and NUVO dropped sharply today on analyst downgrades. I find that funny that the stocks dropped as if they were ever trading on analysts buy and sell recommendations anyway. These stocks are thriving on the fear and greed of investors. NUVO is mimicking DNDN's movement which is telling. Today DNDN filled it's gap down to $18 where I think it should hold fairly steady in the $17 to $18 range before heading higher. Considering the fact that NUVO follows DNDN I think it will briefly fill the gap down to $4 to stay consistent with DNDN. I think this is temporary as both stocks should continue their upward movement in anticipation of the May 15th announcement from the FDA. I think the current prices are good entry points with high profit potential since both of these stocks are hot and volume is still strong. Check back later tonight for tomorrow's recommendation.